Back to Journals » ClinicoEconomics and Outcomes Research » Volume 16 » Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Please verify you are not a robot.
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 16 » Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Please verify you are not a robot.